HOME >> BIOLOGY >> NEWS
UC Davis to begin identifying eligible families for study on environmental factors in autism

(SACRAMENTO, CALIF.) -- UC Davis researchers are ready to launch the first-ever major epidemiological case-control study of up to 2,000 California children to examine genetic and environmental factors that may affect the development of autism, mental retardation and developmental delay in children.

Parents of children who recently have become eligible to receive services from California's Regional Centers will receive information on how their child can join the Childhood Autism Risks from Genetics and the Environment (CHARGE) study of children between 2 and 5 years of age. Recruitment will continue over the next three years as newly diagnosed children enter the Regional Center system, which coordinates services to developmentally disabled children and adults for the California Department of Developmental Services (DDS).

This study is one of three projects within the UC Davis Center for Children's Environmental Health and Disease Prevention, that was created last fall with grants from the National Institute of Environmental Health Sciences, the U.S. Environmental Protection Agency and the M.I.N.D. Institute at UC Davis. The center is the first to specifically look at severe impairments of social behavior in relation to both genetic and environmental factors. "Most importantly, our researchers will be tackling how genes and environmental factors interact," said Isaac Pessah, the center director and professor of molecular biosciences at UC Davis School of Veterinary Medicine.

"It's clear that genes play a role in autism and developmental delay, but evidence suggests that the environment is also an important factor," said Irva Hertz-Picciotto, professor of epidemiology and preventive medicine at UC Davis School of Medicine and Medical Center. "By studying a large number of children with different types of development, we expect to gain a better understanding of the multiple ways autism and other developmental delays may occur." Hertz-Picciotto,
'"/>

Contact: Martha Alcott
martha.alcott@ucdmc.ucdavis.edu
916-734-9027
University of California, Davis - Health System
5-Dec-2002


Page: 1 2 3

Related biology news :

1. Controversial UK badger killings analyzed by UC Davis expert
2. New angle needed to get pike out of Lake Davis
3. NSF establishes center for biophotonics at UC Davis
4. UC Davis mathematician, neuroscientist win Sloan Fellowships
5. Next-generation AIDS vaccine for healthy individuals being tested for safety, tolerability at UC Davis
6. UC Davis first cloned calf born, succumbs three days later
7. UC Davis biomedical engineering department awarded $12 million by Whitaker Foundation
8. UC Davis study finds breastfeeding may protect bones in teen-age mothers
9. UC Davis, Santa Barbara get $6 million to help estuaries
10. UC Davis science, engineering and technology newstips -- March
11. UC Davis study finds heart benefits from apples & juice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical ... discover a COVID cure or vaccine, the global economic downturn will only increase price ... not going away and capturing full value from every product launch is critical. However, ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the ... share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content ... will be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the ...
(Date:7/2/2020)... REDWOOD CITY, Calif. (PRWEB) , ... July 01, ... ... stage biotech company, presented its phase 1a findings of Neihulizumab, a biologic for ... annual conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... July 29, 2020 , ... ... cell joint injections for only $3950. With 50 million stem cells total, patients may ... well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... entered into a strategic partnership whereby Catalent will provide support for the development, ...
(Date:7/22/2020)... ... ... Join experts from Reed Tech , Gary Saner, Sr. Manager, Information ... live webinar on Thursday, August 13, 2020 at 11am EDT (4pm BST/UK). ... Specifically, for medical devices, the NMPA has departments dealing with medical device registration (pre-market ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
Breaking Biology Technology:
Cached News: